Skip to main content
Caplight Logo









Ophthalmic Sciences Ltd.

Ophthalmic Sciences Ltd.

Private
Tel AvivHealthcare & Life Scienceshttps://op-sci.com

Last Round

Seed

Jan 27, 2022

Total Funding Raised

$1.95M

Company Overview

Ophthalmic Sciences Ltd. is a health tech company that develops AI-based, contact-free intraocular pressure measurement devices for remote glaucoma monitoring and telemedicine.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Medical Imaging, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

glaucoma monitoringintraocular pressureIOPtonometernon-contact tonometrymedical AIremote eye caretele-ophthalmologydigital healthdiagnostic hardwareophthalmic imagingremote patient monitoringRPMhealth IoTAI diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ophthalmic Sciences Ltd. Comparables

Compare Ophthalmic Sciences Ltd. with similar companies based on industry and business-model similarity.

Ophthalmic Sciences Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eye to Eye Telehealth
82%
Revenio Group
78%
Hamamatsu Vision Technology
77%

Ophthalmic Sciences Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 27, 2022
Pre SeedOct 1, 2019

Ophthalmic Sciences Ltd. Investors

Notable investors and investment history

Ophthalmic Sciences Ltd. investors
InvestorRounds
Israel Innovation AuthorityPre Seed
eHealth VenturesPre Seed, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 27, 2022

    $1.1M round led by eHealth Ventures

  • Oct 1, 2019

    $850K raised from eHealth Ventures and Israel Innovation Authority.

Ophthalmic Sciences Ltd. Filings

Explore SEC and related filing metadata, where available.

Ophthalmic Sciences Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ophthalmic Sciences Ltd.'s valuation, stock price, and market status.

Is Ophthalmic Sciences Ltd. a public or private company?

Ophthalmic Sciences Ltd. is a private company.

What is the current stock price of Ophthalmic Sciences Ltd.?

Ophthalmic Sciences Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is Ophthalmic Sciences Ltd. worth (valuation)?

Valuation information for Ophthalmic Sciences Ltd. is not publicly available.

Can I buy Ophthalmic Sciences Ltd. stock?

Ophthalmic Sciences Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ophthalmic Sciences Ltd.'s last funding round?

Ophthalmic Sciences Ltd.'s most recent funding round was Seed on January 27, 2022.

Who are the main investors in Ophthalmic Sciences Ltd.?

Key investors in Ophthalmic Sciences Ltd. include eHealth Ventures.

Will Ophthalmic Sciences Ltd. IPO soon?

No public IPO plans have been announced for Ophthalmic Sciences Ltd..

How can I track Ophthalmic Sciences Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ophthalmic Sciences Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTel Aviv
Employee Range2
Year Founded2019
Last FundingJan 27, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?